Symbol="CGEM"
AssetType="Common Stock"
Name="Cullinan Oncology LLC"
Description="Cullinan Management, Inc., a biopharmaceutical company, is focused on developing a line of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1789972"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="ONE MAIN STREET, SUITE 520, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="407779000"
EBITDA="-160084000"
PERatio="8.93"
PEGRatio="None"
BookValue="12.34"
DividendPerShare="0"
DividendYield="0"
EPS="1.16"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.21"
ReturnOnEquityTTM="0.141"
RevenueTTM="0"
GrossProfitTTM="18943000"
DilutedEPSTTM="1.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="29"
TrailingPE="8.93"
ForwardPE="6.3"
PriceToSalesRatioTTM="26.88"
PriceToBookRatio="0.91"
EVToRevenue="11.55"
EVToEBITDA="0.284"
Beta="0.154"
num_52WeekHigh="14.37"
num_52WeekLow="7.78"
num_50DayMovingAverage="11.14"
num_200DayMovingAverage="11.08"
SharesOutstanding="39360900"
DividendDate="None"
ExDividendDate="None"
symbol="CGEM"
open="10.53"
high="10.79"
low="10.28"
price="10.36"
volume="143785.00"
latest_trading_day="2023-08-09"
previous_close="10.52"
change="-0.16"
change_percent="-1.5209%"
aroon_positive_momentum_days="54"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="277355"
Change_recent_avg="0.01"
Delta_recent_avg="0.59"
Variance_recent_avg="0.3"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_45"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="508"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0097.jpeg"
image_negative_thumbnail_id_2="149"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0027.jpeg"
image_neutral_thumbnail_id_1="534"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="620"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0088.jpeg"
image_positive_thumbnail_id_2="969"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0131.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
